Solventum Total Non-Operating Income/Expense 2023-2025 | SOLV

Solventum annual/quarterly total non-operating income/expense history and growth rate from 2023 to 2025. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
  • Solventum total non-operating income/expense for the quarter ending June 30, 2025 was $-0.111B, a 25% decline year-over-year.
  • Solventum total non-operating income/expense for the twelve months ending June 30, 2025 was $-0.457B, a 108.68% increase year-over-year.
  • Solventum annual total non-operating income/expense for 2024 was $-0.431B, a 1624% increase from 2023.
  • Solventum annual total non-operating income/expense for 2023 was $-0.025B, a 2400% increase from 2022.
  • Solventum annual total non-operating income/expense for 2022 was $-0.001B, a 0% decline from .
Solventum Annual Total Non-Operating Income/Expense
(Millions of US $)
2024 $-431
2023 $-25
2022 $-1
Solventum Quarterly Total Non-Operating Income/Expense
(Millions of US $)
2025-06-30 $-111
2025-03-31 $-115
2024-12-31 $-123
2024-09-30 $-108
2024-06-30 $-148
2024-03-31 $-52
2023-12-31 $-15
2023-09-30 $-4
2023-06-30 $-4
2023-03-31 $-2
2022-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $12.643B $8.254B
Solventum is an independent healthcare company. Its business segment includes Medical Surgical, Dental Solutions, Health Information Systems and Purification and Filtration. Solventum is based in ST. PAUL, Minn.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $147.686B 27.39
CVS Health (CVS) United States $90.749B 11.28
Elevance Health (ELV) United States $69.812B 9.39
Cencora (COR) United States $56.166B 18.70
DiDi Global (DIDIY) China $27.862B 29.60
Labcorp Holdings (LH) United States $23.139B 18.39
Natera (NTRA) United States $22.743B 0.00
BioMerieux (BMXMF) France $17.423B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $14.474B 0.00
ICON (ICLR) Ireland $13.871B 13.35
Medpace Holdings (MEDP) United States $13.184B 34.89
CochLear (CHEOY) Australia $12.924B 0.00
Viatris (VTRS) United States $12.137B 4.32
Caris Life Sciences,�Inc (CAI) United States $10.796B 0.00
Revvity (RVTY) United States $10.589B 18.66
Avantor (AVTR) United States $9.067B 13.30
Charles River Laboratories (CRL) United States $8.057B 15.29
Sonic Healthcare (SKHHY) Australia $7.725B 0.00
HealthEquity (HQY) United States $7.725B 33.84
Bausch + Lomb (BLCO) Canada $5.112B 34.38
Sotera Health (SHC) United States $4.658B 26.03
BrightSpring Health Services (BTSG) United States $4.246B 32.39
Amplifon S.p.A (AMFPF) Italy $3.937B 21.83
GeneDx Holdings (WGS) United States $3.627B 83.06
Alignment Healthcare (ALHC) United States $3.105B 0.00
KindlyMD (NAKA) United States $3.035B 0.00
Concentras Parent (CON) United States $2.930B 18.58
Surgery Partners (SGRY) United States $2.909B 36.60
Organon (OGN) United States $2.358B 2.57
Premier (PINC) United States $2.129B 19.74
Progyny (PGNY) United States $1.947B 41.16
Ardent Health (ARDT) United States $1.793B 6.92
PACS (PACS) United States $1.777B 0.00
GoodRx Holdings (GDRX) United States $1.504B 25.47
Pediatrix Medical (MD) United States $1.483B 9.90
Teladoc Health (TDOC) United States $1.380B 0.00
Omada Health (OMDA) $1.246B 0.00
Establishment Labs Holdings (ESTA) $1.210B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.962B 0.00
Embecta (EMBC) United States $0.831B 4.87
AMN Healthcare Services Inc (AMN) United States $0.780B 9.64
CareDx (CDNA) United States $0.682B 12.56
Performant Healthcare (PHLT) United States $0.600B 0.00
InnovAge Holding (INNV) United States $0.524B 0.00
Agilon Health (AGL) United States $0.510B 0.00
Nutex Health (NUTX) United States $0.500B 7.57
Sonida Senior Living (SNDA) United States $0.495B 0.00
QDM (QDMI) Hong Kong, SAR China $0.493B 84.50
COMPASS Pathways (CMPS) United Kingdom $0.457B 0.00
Auna S.A (AUNA) Luxembourg $0.455B 6.83
So-Young (SY) China $0.433B 0.00
SBC Medicals (SBC) United States $0.426B 9.32
Enhabit (EHAB) United States $0.402B 26.47
Oncology Institute (TOI) United States $0.326B 0.00
LifeMD (LFMD) United States $0.308B 0.00
Beauty Health (SKIN) United States $0.257B 0.00
Shoulder Innovations (SI) United States $0.227B 0.00
DocGo (DCGO) United States $0.161B 0.00
Ascend Wellness Holdings (AAWH) United States $0.149B 0.00
Sera Prognostics (SERA) United States $0.115B 0.00
Biodesix (BDSX) United States $0.068B 0.00
NeueHealth (NEUE) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.039B 0.00
Basel Medical Group (BMGL) Singapore $0.037B 0.00
SeaStar Medical Holding (ICU) United States $0.025B 0.00
OSR Holdings (OSRH) United States $0.021B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.012B 0.00
BioNexus Gene Lab (BGLC) $0.010B 0.00
ModivCare (MODV) United States $0.008B 0.00
XWELL (XWEL) United States $0.006B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.004B 0.00
Pheton Holdings (PTHL) China $0.004B 0.00
Aclarion (ACON) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00